ALTERNATIVE FINANCING FORMS
FOR ENTREPRENEURS AND INVESTORS
News
Photo:   Jens Cremer, Managing Partner and co-founder of GREENPEAK (Photo: Greenpeak Partners)

GREENPEAK Partners: CERTANIA GRUPPE takes over Alphalytik

Photo: Jens Cremer, Mana­ging Part­ner and co-foun­der of GREENPEAK (Photo: Green­peak Partners)
6. Septem­ber 2024

Berlin/ Munich — Alpha­ly­tik Phar­ma­ser­vice GmbH, a leading expert in phar­maceu­ti­cal analy­tics, announ­ces its inte­gra­tion into GREENPEAK Part­ners’ subsi­diary, the CERTANIA Group, a dyna­mic group specia­li­zing in test­ing, inspec­tion and certi­fi­ca­tion services.
This stra­te­gic move repres­ents a signi­fi­cant mile­stone for Alpha­ly­tik as it expands its offe­ring of specia­li­zed stabi­lity test­ing and method vali­da­tion services to a broa­der range of phar­maceu­ti­cal clients. Alpha­ly­tik was foun­ded in 1995 and is head­quar­te­red in Berlin, Germany.
Alpha­ly­tik has built a strong repu­ta­tion as an inde­pen­dent labo­ra­tory specia­li­zing in drug product stabi­lity test­ing, method deve­lo­p­ment and release test­ing under Good Manu­fac­tu­ring Prac­tice (GMP) and US Food and Drug Admi­nis­tra­tion (FDA) guidelines.
With a focus on complex drug formu­la­ti­ons, inclu­ding low-dose and hormo­nal prepa­ra­ti­ons, Alpha­ly­tik serves a diverse custo­mer base that includes some of the world’s leading phar­maceu­ti­cal companies.
The company’s exper­tise in ensu­ring the long-term safety and effi­cacy of phar­maceu­ti­cal products makes it a relia­ble partner.
The merger with CERTANIA will give Alpha­ly­tik access to a powerful plat­form that will enable it to expand its service offe­ring and streng­then its posi­tion in the phar­maceu­ti­cal analy­tics market.
This part­ner­ship will enable Alpha­ly­tik to meet the growing demand for specia­li­zed phar­maceu­ti­cal test­ing services driven by incre­asing drug deve­lo­p­ment and regu­la­tory requirements.
Dr. Nico­las Schauer has been appoin­ted as the new Mana­ging Direc­tor, while Dr. Richard Herzog, the foun­der of Alpha­ly­tik, will conti­nue to support the company in an advi­sory capa­city to ensure a seam­less tran­si­tion and conti­nuity in custo­mer relationships.
“We are exci­ted to join CERTANIA, a group that shares our commit­ment to excel­lence in phar­maceu­ti­cal test­ing,” said Dr. Richard Herzog, foun­der of Alphalytik.
“This part­ner­ship will provide us with the resour­ces and support we need to conti­nue provi­ding high-quality, relia­ble services to our custo­mers while pursuing new growth oppor­tu­ni­ties.” Kars­ten Xander, CEO and foun­der of CERTANIA, welco­med Alpha­ly­tik to the group and empha­si­zed the stra­te­gic importance of the acquisition.
“The addi­tion of Alpha­ly­tik signi­fi­cantly streng­thens CERTANIA’s posi­tion in the field of phar­maceu­ti­cal labo­ra­tory analy­tics. Their exper­tise in stabi­lity test­ing and method vali­da­tion comple­ments our exis­ting services and we see great poten­tial for syner­gies and growth.”
The acqui­si­tion of Alpha­ly­tik by CERTANIA under­lines the Group’s commit­ment to expan­ding its compe­ten­cies in the life scien­ces and streng­thening its market presence in Germany and beyond.
The inte­gra­tion is expec­ted to drive inno­va­tion, enhance the service offe­ring and promote signi­fi­cant growth within the CERTANIA Group. CERTANIA offers medium-sized, know­­ledge-based compa­nies a plat­form to deve­lop under one roof, retain entre­pre­neu­rial free­dom and at the same time bene­fit from the resour­ces and support of the group. About Alpha­ly­tik: Foun­ded in 1995 and head­quar­te­red in Berlin, Alpha­ly­tik Phar­ma­ser­vice GmbH is a specia­li­zed phar­maceu­ti­cal labo­ra­tory offe­ring stabi­lity test­ing, method deve­lo­p­ment and release test­ing for medi­cinal products.
With a focus on complex analy­ti­cal requi­re­ments, Alpha­ly­tik serves a diverse clientele, inclu­ding leading phar­maceu­ti­cal companies.
The company’s exper­tise and accre­di­ted services ensure the long-term safety and effi­cacy of phar­maceu­ti­cal products.
For more infor­ma­tion, visit alphalytik.com. About CERTANIA: Under the umbrella of CERTANIA Holding GmbH, a new global market player in the fields of Test­ing, Inspec­tion & Certi­fi­ca­tion is emerging.
The group offers medium-sized part­ners a sustainable home for their life’s work.
CERTANIA enables entre­pre­neurs and owners to deve­lop their busi­ness with like-minded people while preser­ving their entre­pre­neu­rial roots, corpo­rate culture, brand and values.
More infor­ma­tion at certania.com  

Subscribe newsletter

Here you can read about the latest transactions, IPOs, private equity deals and venture capital investments, who has raised a new fund, how Buy & Build activities are going.

Get in touch

Contact us!
fyb [at] fyb.de